Hypertension and lung cancer in China (2002–2019): A nationwide study of temporal trends, demographic disparities, and independent risk associations
Hypertension is highly prevalent among lung cancer patients in China and appears to be independently associated with increased lung cancer risk. These findings suggest the need for integrated cardio-oncology surveillance and prevention strategies, particularly for high-risk subpopulations such as older adults, women, and non-smokers. Further prospective studies are warranted to explore the mechanisms underlying this association and to evaluate whether hypertension control may influence lung cancer burden.
Authors
- Yan Gao (ORCID: https://orcid.org/0000-0002-7282-4530)
- Rui He (ORCID: https://orcid.org/0009-0000-8256-1474)
- J Chen (ORCID: https://orcid.org/0000-0003-2852-7667)
- Chongcheng Xi (ORCID: https://orcid.org/0000-0003-2467-845X)
- Quansheng Feng (ORCID: https://orcid.org/0000-0003-3437-8987)
- Dingqi Li
- Yang Yu (ORCID: https://orcid.org/0000-0002-7464-2079)
Institutions
- Chengdu University of Information Technology (CN)
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- International Journal of Cardiology Cardiovascular Risk and Prevention
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1016/j.ijcrp.2025.200515
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00